Statins in type 2 diabetics having macrovascular disease, still a long way to go
Basit, A.; Hydrie, M.Z.I.; Ahmedani, M.Y.
Jpma. Journal of the Pakistan Medical Association 54(5): 289
2004
ISSN/ISBN: 0030-9982 PMID: 15270195 Document Number: 568906
Document emailed within 1 workday
Related Documents
Weber, S. 2013: Multimorbidity, long-standing type 2 diabetics. HbA1c to 6.5% - must it be? MMW Fortschritte der Medizin 155(21-22): 32Dandona, P.; Chaudhuri, A. 2008: Glycaemic control and macrovascular complications of type 2 diabetes National Medical Journal of India 21(6): 271-274
Mundo-Sagardía, J.; Altieri, P.; Banch, H.; González, R.; Escobales, N.; Crespo, M.; Rodríguez-Orengo, J.; Cardona, F.; Torrado, J. 2003: Role of endothelin i and angiotensin Ii in type 2 diabetics with coronary disease Boletin de la Asociacion Medica de Puerto Rico 95(5): 45-50
Akram, J.; Aamir, A.-u.-h.; Basit, A.; Qureshi, M.S.; Mehmood, T.; Shahid, S.K.; Khoso, I.A.; Ebrahim, M.A.; Omair, A. 2011: Prevalence of peripheral arterial disease in type 2 diabetics in Pakistan JPMA. Journal of the Pakistan Medical Association 61(7): 644-648
Rastogi, D.K.; Gupta, O.P.; Agarwal, B.L. 1978: Study of peripheral vascular disease in long term diabetics Journal of the Indian Medical Association 71(11): 283-285
Jain, S. 2020: Study of Serum Magnesium Level in Type 2 Diabetes Mellitus Patients with Special Emphasis on Microvascular Macrovascular Complications Journal of the Association of Physicians of India 68(1): 50
Andersch, H.; Arzberger, H.; Köhler, W. 1970: Ankylosing hyperostosis of the spine (Forestier's disease) in diabetics. Systematic x-ray examinations of 1,000 diabetics Das Deutsche Gesundheitswesen 25(42): 1991-1994
Ali, M.K.; Narayan, K.M.V. 2009: Glycaemic control and macrovascular disease in people with diabetes mellitus National Medical Journal of India 22(1): 39-40
Zeng, Y.; Li, M.; Xu, D.; Hou, Y.; Wang, Q.; Fang, Q.; Sun, Q.; Zhang, S.; Zeng, X. 2012: Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity Clinical and Experimental Rheumatology 30(2 Suppl 71: S76-S80
Lenhard, M.J. 1995: Predicting renal disease in type i diabetics: smoke and fire or smoke and mirrors? Delaware Medical Journal 67(7): 378-387
Agarwal, A.K.; Singla, S.; Singla, S.; Singla, R.; Lal, A.; Wardhan, H.; Yadav, R. 2009: Prevalence of coronary risk factors in type 2 diabetics without manifestations of overt coronary heart disease Journal of the Association of Physicians of India 57(1): 135-142
Hager, J.; Forssell, C. 2005: A new vascular disease entity in HIV/AIDS. Earlier unknown macrovascular changes in young patients Lakartidningen 102(1-2): 36-37
Schlumpf, U. 1978: The effect of diclofenac sodium on the metabolism of diabetics in qualitative diet therapy with an without tolbuamide. a clinically oriented study in aged diabetics with rheumatic disease Schweizerische Medizinische Wochenschrift 108(1): 28-34
Elias, A.N.; Domurat, E.S.; Friis, R.; Valenta, L.J. 1989: Correlation between macrovascular disease as assessed by bioimpedance plethysmography and various parameters used to assess diabetic "control" Journal of the National Medical Association 81(4): 357-362
1998: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group Bmj 317(7160): 713-720
2003: Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins Prescrire International 12(66): 143-148
Avgerinos, E.D.; Kakisis, J.D.; Moulakakis, K.G.; Giannakopoulos, T.G.; Sfyroeras, G.; Antonopoulos, C.N.; Kadoglou, N.P.; Liapi, C.D. 2015: Statins influence long term restenosis and cardiovascular events following carotid endarterectomy Current Vascular Pharmacology 13(2): 239-247
Kadowaki, T. 2010: Diabetic treatment strategies to control the onset and development of diabetic macrovascular disease Nihon Rinsho. Japanese Journal of Clinical Medicine 68(5): 788-795
Niederau, C.; vom Dahl, S.; Häussinger, D. 1998: First long-term results of imiglucerase therapy of type 1 Gaucher disease European Journal of Medical Research 3(1-2): 25-30
Matovinović, M.S. 2006: Chronic kidney disease and statins Lijecnicki Vjesnik 128(11-12): 345-350